8th Circ. Affirms Novartis Loss In Aredia, Zometa Suit

Law360, New York (January 9, 2014, 3:35 PM EST) -- The Eighth Circuit on Thursday upheld a verdict against Novartis Pharmaceuticals Corp. in a lawsuit over a jaw injury allegedly caused by a woman's use of the bone drugs Aredia and Zometa, even though her physician said he did not read drug warnings.

The decision affirms the $225,000 in compensatory damages awarded to the estate of Ruth Baldwin, the now-deceased plaintiff, in April 2012. Baldwin claimed that Novartis failed to warn that her use of Aredia and Zometa could cause her to develop osteonecrosis of the...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Christine Winter v. Novartis Pharmaceuticals Corp.


Case Number

12-3121

Court

Appellate - 8th Circuit

Nature of Suit

3365 Personal Injury-Product Liability

Date Filed

September 7, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.